Nanocarriers offer several advantages over traditional cancer therapies:
Targeted delivery: They can be functionalized with ligands that specifically bind to cancer cell receptors, enhancing specificity. Reduced toxicity: By localizing the drug at the tumor site, they minimize the adverse effects on healthy tissues. Enhanced solubility: They improve the solubility of poorly water-soluble drugs, increasing their bioavailability. Controlled release: They can be engineered to release their payload in response to specific stimuli, ensuring a sustained therapeutic effect.
